South Africa Central Nervous System (CNS) Therapeutic Market Insights by 2027

The South Africa Central Nervous System (CNS) Therapeutic market is expected to reach US$ 3,686.91 Mn in 2027 from US$ 2,267.59 Mn in 2018. The market is estimated to grow with a CAGR of 5.6% from 2019-2027 from 2019-2027

Rising prevalence of CNS diseases such as malnutrition, malaria, the human immunodeficiency virus & the acquired immune deficiency syndrome (HIV/AIDS), and demographic transitions are expected to surge the market growth. However, high cost of treatment is likely to have a negative impact on the growth of the market in the coming years.

Neurological disorders are very prevalent in Sub-Saharan Africa. The factors responsible for the growing burden include difficult perinatal situations, malnutrition, malaria, the human immunodeficiency virus & the acquired immune deficiency syndrome (HIV/AIDS), and demographic transitions. The primary neurological disorders include mental retardation, cerebral palsy, developmental disorders, epilepsy, peripheral neuropathy, stroke, trauma, and alcohol abuse. According to South African Pharmaceutical Journal in 2016, an estimated 818, 106 people are getting dementia per year, presently affecting more than 4 million people. The number is anticipated to be more than 14 million by 2050. Furthermore, HIV-associated dementia (HAD) is dominant in 15–30% of untreated adults with late-stage disease. The elderly patients, who previously have an increased risk of non-AIDS related dementias, are more prone to untreated HIV. Such a rising prevalence of CNS disorders is expected to create a demand for the central nervous system (CNS) therapeutic across the world.

South Africa Central Nervous System (CNS) Therapeutic market, based on drug type was segmented into analgesics, nervous system drugs, anesthetics, anti-parkinson drugs, anti-epileptics, others. In 2018, the analgesics segment held the largest share of the market, by drug type. This segment is also anticipated to grow at the highest rate during the forecast period because they are used to relive pain which provides relief to patients without being consciousness.

South Africa Drug Type Market Revenue and Forecasts to 2027 (US$ Mn)

South Africa Central Nervous System (CNS) Therapeutic – MARKET SEGMENTATION

By Disease Type

• Neurovascular Diseases
• Degenerative Disorders
• Mental Health
• Trauma
• Others

By Drug Type

• analgesics
• Nervous System Drugs
• Anesthetics
• Anti-Parkinson Drugs
• Anti-Epileptics
• Others

By Distribution Channel

• Hospitals Pharmacies
• Retail Pharmacies

Companies Mentioned

• Eli Lilly and company
• Pfizer Inc.
• Merck & Co., Inc.
• AstraZeneca
• Novartis AG
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceutical Industries Ltd.
• Lundbeck
• Adcock Ingram
• Lupin Limited

South Africa Central Nervous System (CNS) Therapeutic Report Scope